Verified Nov 2026
Other
·

The Woodlands, Texas
·
Since 1995
Lexicon Pharmaceuticals is a biopharmaceutical company headquartered in The Woodlands, Texas, founded in 1995. With 50 to 100 employees and estimated revenue between $10 million and $50 million, the privately held firm uses gene knockout technology to discover and develop medicines for cardiometabolic disorders, neuropathic pain, and obesity. The company markets INPEFA, an approved oral tablet for heart failure and type 2 diabetes, and maintains a pipeline including candidates for type 1 diabetes and chronic pain conditions.
Lexicon Pharmaceuticals, Inc. at a glance
Revenue
$10-50M
Est. band
Employees
50-100
Founded
1995
Headquarters
The Woodlands, Texas
Industries
Automotive
Electric Vehicles
Medical
Overview
Lexicon Pharmaceuticals is a biopharmaceutical company headquartered in The Woodlands, Texas, founded in 1995. With 50 to 100 employees and estimated revenue between $10 million and $50 million, the privately held firm uses gene knockout technology to discover and develop medicines for cardiometabolic disorders, neuropathic pain, and obesity. The company markets INPEFA, an approved oral tablet for heart failure and type 2 diabetes, and maintains a pipeline including candidates for type 1 diabetes and chronic pain conditions.
At a glance
Attribute | Detail |
|---|---|
Founded | 1995 |
Headquarters | The Woodlands, Texas |
Employees | 50-100 |
Revenue | $10-50M (estimated) |
What Lexicon Pharmaceuticals, Inc. makes
The company employs proprietary gene knockout technology to study human diseases and has collaborations with major pharmaceutical firms including Bristol-Myers Squibb and Genentech.
Latest developments
2026-11-05 — Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates | November 5, 2026 (lexpharma.com)
2026-08-24 — Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851 - BioSpace (biospace.com)
2026-05-13 — Why Lexicon is in ‘good shape to go crazy’: CEO (fiercebiotech.com)
2026-05-04 — Lexicon Pharmaceuticals Announces $100 Million Loan (globenewswire.com)
2026-03-05 — Lexicon Pharmaceuticals Reports Fourth Quarter 2025 (globenewswire.com)
2026-01-21 — Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain | January 21, 2026 (lexpharma.com)
Company details
Lexicon is a privately held biopharmaceutical enterprise with one approved product on the market and multiple drug candidates in development. Lexicon Pharmaceuticals, Inc. was founded in 1995, has an estimated 50-100 employees, and is headquartered in The Woodlands, Texas.
Frequently asked questions
What does Lexicon Pharmaceuticals, Inc. do?
Lexicon Pharmaceuticals is a biopharmaceutical company headquartered in The Woodlands, Texas, founded in 1995. With 50 to 100 employees and estimated revenue between $10 million and $50 million, the privately held firm uses gene knockout technology to discover and develop medicines for cardiometabolic disorders, neuropathic pain, and obesity. The company markets INPEFA, an approved oral tablet for heart failure and type 2 diabetes, and maintains a pipeline including candidates for type 1 diabetes and chronic pain conditions.
Where is Lexicon Pharmaceuticals, Inc. headquartered?
Lexicon Pharmaceuticals, Inc. is headquartered in The Woodlands, Texas (8800 Technology Forest Place, The Woodlands, Texas, 77381).
When was Lexicon Pharmaceuticals, Inc. founded?
Lexicon Pharmaceuticals, Inc. was founded in 1995.
How big is Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. has an estimated 50-100 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
